Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886 · see citing works

Fibrinogen and fibrin structure and functions

MOSESSON, M. W. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01365.x · Cited by 1,695 · see citing works

Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357 · cited 1× · see citing works

Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Hoylaerts, M., Rijken, D. C., LIJNEN, H. R., & Collen, D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81051-7 · Cited by 1,312 · see citing works

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

Boerwinkle, E., Leffert, C. C., Lin, J., Lackner, C., Chiesa, G., & Hobbs, H. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115855 · Cited by 958 · see citing works

Cardiovascular Risk Factors and Venous Thromboembolism Incidence

Tsai, A. W., Cushman, M., Rosamond, W. D., Heckbert, S. R., Polak, J. F., & Folsom, A. R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1182 · Cited by 699 · see citing works

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

Hajjar, K. A., Gavishi, D., Breslow, J. L., & Nachman, R. L. (1989) · Nature · doi:10.1038/339303a0 · Cited by 699 · see citing works

A potential basis for the thrombotic risks associated with lipoprotein(a)

Miles, L. A., Fless, G. M., Levin, E. G., Scanu, A. M., & Plow, E. F. (1989) · Nature · doi:10.1038/339301a0 · Cited by 581 · see citing works

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.

Sørensen, K. E., Celermajer, D. S., Georgakopoulos, D., Hatcher, G. W., Betteridge, D. J., & Deanfield, J. E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116983 · Cited by 578 · see citing works

Fibrin Clot Structure and Function

Undas, A., & Ariëns, R. A. S. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.230631 · Cited by 526 · see citing works

Lipoprotein(a): resurrected by genetics

Kronenberg, F., & Utermann, G. (2013) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02592.x · Cited by 521 · see citing works

Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules

Patthy, L. (1985) · Cell · doi:10.1016/s0092-8674(85)80046-5 · Cited by 493 · see citing works

Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis Speed

Collet, J. ‐., Park, D., Lesty, C., Soria, J., Soria, C., Montalescot, G., & Weisel, J. W. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1354 · Cited by 492 · see citing works

The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action

Broze, G. J., Warren, L., Novotny, W., et al. (1988) · Blood · doi:10.1182/blood.v71.2.335.335 · Cited by 481 · see citing works

Lipoprotein(a), fibrin binding, and plasminogen activation.

Loscalzo, J., Weinfeld, M. S., Fless, G. M., & Scanu, A. M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.240 · Cited by 461 · see citing works

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

Eaton, D., Fless, G. M., Kohr, W. J., McLean, J. W., Xu, Q., Miller, C. G., Lawn, R. M., & Scanu, A. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3224 · Cited by 417 · see citing works

Molecular mechanism of physiological fibrinolysis

Wiman, B., & Collen, D. (1978) · Nature · doi:10.1038/272549a0 · Cited by 417 · see citing works

A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma

Bergmark, C., Dewan, A. K., Orsoni, A., Merki, E., Miller, E. R., Shin, M., Binder, C. J., Hörkkö, S., Krauss, R. M., Chapman, M. J., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800174-jlr200 · Cited by 410 · see citing works

Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis

Jp, C., Allali, Y., Lesty, C., Tanguy, M., Silvain, J., Ankri, A., Blanchet, B., Dumaine, R. L., Gianetti, J., Payot, L., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000241589.52950.4c · Cited by 348 · see citing works

Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood

Nowak‐Göttl, U., Sträter, R., Heinecke, A., Junker, R., Koch, H.-G., Schuierer, G. R., & von Eckardstein, A. (1999) · Blood · doi:10.1182/blood.v94.11.3678 · Cited by 343 · see citing works

Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study

Sträter, R., Becker, S., von Eckardstein, A., Heinecke, A., Gutsche, S., Junker, R., Kurnik, K., Schobeß, R., & Nowak‐Göttl, U. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11520-0 · Cited by 333 · see citing works

Molecular definition of the extreme size polymorphism in apolipoprotein(a)

Lackner, C., Cohen, J. C., & Hobbs, H. H. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.933 · Cited by 320 · see citing works

Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease

Berg, K., Dahlén, G. H., & Frick, M. H. (1974) · Clinical Genetics · doi:10.1111/j.1399-0004.1974.tb00657.x · Cited by 319 · see citing works

Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis

Kronenberg, F., Kronenberg, M. F., Kiechl, S. J., Trenkwalder, E., Santer, P., Oberhollenzer, F., Egger, G., Utermann, G., & Willeit, J. (1999) · Circulation · doi:10.1161/01.cir.100.11.1154 · Cited by 292 · see citing works

Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)

Willeit, P., Kiechl, S., Kronenberg, F., Witztum, J. L., Santer, P., Mayr, M., Xu, Q., Mayr, A., Willeit, J., & Tsimikas, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.061 · Cited by 286 · see citing works

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors

Nowak‐Göttl, U. (2001) · Blood · doi:10.1182/blood.v97.4.858 · Cited by 252 · see citing works

Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)

Leibundgut, G., Scipione, C. A., Yin, H., Schneider, M., Boffa, M. B., Green, S., Yang, X., Dennis, E. A., Witztum, J. L., Koschinsky, M. L., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m040733 · Cited by 246 · see citing works

Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans

Marcovina, S. M., Albers, J. J., Wijsman, E. M., ZHANG, Z., Chapman, N. H., & Kennedy, H. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37461-7 · Cited by 236 · see citing works

Molecular cloning and characterization of a full‐length cDNA clone for human plasminogen

Forsgren, M., RÅDÉN, B., Israelsson, M., et al. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81501-6 · Cited by 233 · see citing works

Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis

Caplice, N. M., Panetta, C. J., Peterson, T. E., Kleppe, L. S., Mueske, C. S., Kostner, G. M., Broze, G., & Simari, R. D. (2001) · Blood · doi:10.1182/blood.v98.10.2980 · Cited by 228 · see citing works

Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy

Chasman, D. I., Shiffman, D., Zee, R. Y. L., Louie, J. Z., Luke, M. M., Rowland, C. M., Catanese, J. J., Buring, J. E., Devlin, J. J., & Ridker, P. M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.019 · Cited by 227 · see citing works

Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood

Nowak‐Göttl, U., Junker, R., Hartmeier, M., Koch, H.-G., Münchow, N., Assmann, G., & von Eckardstein, A. (1999) · Circulation · doi:10.1161/01.cir.100.7.743 · Cited by 222 · see citing works

Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis

Kamstrup, P. R., Tybjærg­-Hansen, A., & Nordestgaard, B. G. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.248765 · Cited by 193 · see citing works

Kringles: modules specialized for protein binding

Patthy, L., Trexler, M., Váli, Z., et al. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)80473-1 · Cited by 189 · see citing works

Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysines

Fleury, V., & Anglés‐Cano, E. (1991) · Biochemistry · doi:10.1021/bi00244a035 · Cited by 188 · see citing works

Oxidized Phospholipids on apoB-100-Containing Lipoproteins: a Biomarker Predicting Cardiovascular Disease and Cardiovascular Events

Taleb, A., Witztum, J. L., & Tsimikas, S. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.60 · Cited by 186 · see citing works

Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism

Helgadóttir, A., Grétarsdóttir, S., Þorleifsson, G., Hólm, H., Patel, R. S., Guðnason, Þ., Jones, G. T., van Rij, A. M., Eapen, D. J., Baas, A. F., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.078 · Cited by 185 · see citing works

Rhesus Monkey Apolipoprotein(a)

Tomlinson, J. E., McLean, J. W., & Lawn, R. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83643-2 · Cited by 184 · see citing works

The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms

van der Hoek, Y. Y., Wittekoek, M. E., Beisiegel†, U., Kastelein, J. J. P., & Koschinsky, M. L. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.4.361 · Cited by 183 · see citing works

Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism

von Depka, M., Nowak‐Göttl, U., Eisert, R. M., Dieterich, C., Barthels, M., Scharrer, I., Ganser, A., & Ehrenforth, S. (2000) · Blood · doi:10.1182/blood.v96.10.3364 · Cited by 174 · see citing works

Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin

Mutch, N. J., Engel, R., de Willige, S. U., et al. (2010) · Blood · doi:10.1182/blood-2009-11-254029 · Cited by 167 · see citing works

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

Palabrica, T. M., Liu, A. C., Aronovitz, M. J., Furie, B., Lawn, R. M., & Furie, B. C. (1995) · Nature Medicine · doi:10.1038/nm0395-256 · Cited by 161 · see citing works

A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease

Luke, M. M., Kane, J. P., Liu, D. M., Rowland, C. M., Shiffman, D., Cassano, J., Catanese, J. J., Pullinger, C. R., Leong, D. U., Arellano, A. R., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.141291 · Cited by 159 · see citing works

Inhibition of Plasminogen Activation by Lipoprotein(a)

Hancock, M. A., Boffa, M. B., Marcovina, S. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302780200 · Cited by 153 · see citing works

Molecular Mechanisms Affecting Fibrin Structure and Stability

Lord, S. T. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213389 · Cited by 150 · see citing works

The effect of alpha-,omega-amino acids on human plasminogen structure and activation

Violand, B. N., Byrne, R. E., & Castellino, F. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30384-8 · Cited by 143 · see citing works

Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells

Koschinsky, M. L., Tomlinson, J. E., Zioncheck, T. F., et al. (1991) · Biochemistry · doi:10.1021/bi00234a029 · Cited by 140 · see citing works

Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a)

Edelstein, C., Pfaffinger, D., Hinman, J., Miller, E. R., Lipkind, G. M., Tsimikas, S., Bergmark, C., Getz, G. S., Witztum, J. L., & Scanu, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310425200 · Cited by 137 · see citing works

Inhibition of Fibrinolysis by Lipoprotein(a)

Anglés‐Cano, E., de la Peña-Dı́az, A., & Loyau, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03514.x · Cited by 124 · see citing works

Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity

Allen, S. P., Khan, S., Tam, S., Koschinsky, M. L., Taylor, P., & Yacoub, M. H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1765 · Cited by 122 · see citing works

Factor XII Regulates the Pathological Process of Thrombus Formation on Ruptured Plaques

Kuijpers, M. J. E., van der Meijden, P. E. J., Feijge, M. A. H., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303315 · Cited by 119 · see citing works

Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation.

Desai, K., Bruckdorfer, K. R., Hutton, R. A., & Owen, J. S. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38312-7 · Cited by 117 · see citing works

Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model

Kuijpers, M. J. E., Gilio, K., Reitsma, S., Nergiz‐Unal, R., Prinzen, L., Heeneman, S., Lutgens, E., van Zandvoort, M. A. M. J., Nieswandt, B., Egbrink, M. G. A. O., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03186.x · Cited by 113 · see citing works

Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation

Ezratty, A. M., Simon, D. I., & Loscalzo, J. (1993) · Biochemistry · doi:10.1021/bi00068a021 · Cited by 113 · see citing works

Lp(a) lipoprotein/pre‐ß1‐lipoprotein in Swedish middle‐aged males and in patients with coronary heart disease

Dahlén, G., Berg, K., Gillnäs, T., et al. (1975) · Clinical Genetics · doi:10.1111/j.1399-0004.1975.tb00338.x · Cited by 112 · see citing works

Admission Fibrinolytic Profile Is Associated With Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Tissue Plasminogen Activator

Ribó, M., Montaner, J., Molina, C. A., et al. (2004) · Stroke · doi:10.1161/01.str.0000137608.73660.4c · Cited by 111 · see citing works

Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator

Edelberg, J. M., Gonzalez–Gronow, M., & Pizzo, S. V. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90203-o · Cited by 111 · see citing works

Lipoprotein(a): more interesting than ever after 50 years

Dubé, J. B., Boffa, M. B., Hegele, R. A., & Koschinsky, M. L. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835111d8 · Cited by 105 · see citing works

The refined structure of the .epsilon.-aminocaproic acid complex of human plasminogen kringle 4

Wu, T. P., Padmanabhan, K., Tulinsky, A., et al. (1991) · Biochemistry · doi:10.1021/bi00107a030 · Cited by 102 · see citing works

Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32−36 of Human Apolipoprotein(a)

Ernst, A., Helmhold, M., Brunner, C., Pethö‐Schramm, A., Armstrong, V. W., & Müller, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6227 · Cited by 101 · see citing works

Mechanisms of Lipoprotein(a) Pathogenicity

Spence, J. D., & Koschinsky, M. L. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251306 · Cited by 101 · see citing works

Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator

Montaner, J., Molina, C. A., Arenillas, J. F., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-02-0097 · Cited by 98 · see citing works

Apolipoprotein(a) (Apo(a)) Glycoprotein Isoforms Result from Size Differences in Apo(a) mRNA in Baboons

Hixson, J. E., Britten, M. L., Manis, G. S., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83303-8 · Cited by 93 · see citing works

CC Chemokine I-309 Is the Principal Monocyte Chemoattractant Induced by Apolipoprotein(a) in Human Vascular Endothelial Cells

Haque, N. S., Zhang, X., French, D. L., et al. (2000) · Circulation · doi:10.1161/01.cir.102.7.786 · Cited by 93 · see citing works

The Kringle Domains of Human Plasminogen

Castellino, F., & McCance, S. G. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515457.ch4 · Cited by 91 · see citing works

Lipoprotein (a) and Venous Thromboembolism in Adults: A Meta-Analysis

Sofi, F., Marcucci, R., Abbate, R., Gensini, G. F., & Prisco, D. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.029 · Cited by 89 · see citing works

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study

Lamon‐Fava, S., Marcovina, S. M., Albers, J. J., Kennedy, H., DeLuca, C., White, C. C., Cupples, L. A., McNamara, J. R., SEMAN, L. J., Bongard, V., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012526 · Cited by 89 · see citing works

Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator

Suenson, E., & Petersen, L. C. (1986) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(86)90260-8 · Cited by 84 · see citing works

Apolipoprotein(a) Enhances Platelet Responses to the Thrombin Receptor–Activating Peptide SFLLRN

Rand, M. L., Sangrar, W., Hancock, M. A., et al. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1393 · Cited by 84 · see citing works

Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C‐reactive protein, lipoprotein(a) and homocysteine

Undas, A., Plicner, D., Stępień, E. Ł., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02637.x · Cited by 83 · see citing works

The Recurring Evolution of Lipoprotein(a)

Lawn, R. M., Boonmark, N. W., Schwartz, K., Lindahl, G. E., Wade, D. P., Byrne, C. D., Fong, K. J., Meer, K., & Patthy, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24004 · Cited by 83 · see citing works

Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a)

Romagnuolo, R., Marcovina, S. M., Boffa, M. B., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m036566 · Cited by 83 · see citing works

Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area

Klein, J., Hegele, R. A., Hackam, D. G., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.169292 · Cited by 82 · see citing works

Lipoprotein(a) Selectively Impairs Receptor-Mediated Endothelial Vasodilator Function of the Human Coronary Circulation

Schächinger, V., Halle, M., Minners, J., Berg, A., & Zeiher, A. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00237-4 · Cited by 81 · see citing works

Venous and arterial thrombosis: Different sides of the same coin?

Franchini, M., & Mannucci, P. M. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.10.019 · Cited by 81 · see citing works

Oxidized Phospholipids Are Present on Plasminogen, Affect Fibrinolysis, and Increase Following Acute Myocardial Infarction

Leibundgut, G., Arai, K., Orsoni, A., Yin, H., Scipione, C. A., Miller, E. R., Koschinsky, M. L., Chapman, M. J., Witztum, J. L., & Tsimikas, S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.033 · Cited by 80 · see citing works

Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis

Undas, A., Stępień, E. Ł., Tracz, W., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01903.x · Cited by 80 · see citing works

Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.

Libourel, E. J., Bank, I., Meinardi, J. R., Volkers, C., Hamulyák, K., Middeldorp, S., Koopman, M. M. W., Pampus, E. C. M. V., Prins, M. H., Buller, H. R., et al. (2002) · PubMed · Cited by 79 · see citing works

Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis

Ichinose, A. (1992) · Biochemistry · doi:10.1021/bi00127a011 · Cited by 78 · see citing works

Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction.

Moliterno, D. J., Lange, R. A., Meidell, R. S., et al. (1993) · Circulation · doi:10.1161/01.cir.88.3.935 · Cited by 77 · see citing works

Lipoprotein(a) Assembly

Gabel, B. R., May, L. F., Marcovina, S. M., & Koschinsky, M. L. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1559 · Cited by 77 · see citing works

Analysis of the Proteolytic Activity of a Recombinant Form of Apolipoprotein(a)

Gabel, B. R., & Koschinsky, M. L. (1995) · Biochemistry · doi:10.1021/bi00048a023 · Cited by 76 · see citing works

Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide

Cockell, C. S., Marshall, J. M., Dawson, K. M., et al. (1998) · Biochemical Journal · doi:10.1042/bj3330099 · Cited by 72 · see citing works

The Apolipoprotein(a) Component of Lipoprotein(a) Stimulates Actin Stress Fiber Formation and Loss of Cell-Cell Contact in Cultured Endothelial Cells

Pellegrino, M. W., Furmaniak-Kazmierczak, E., LeBlanc, J. C., Cho, T., Cao, K., Marcovina, S. M., Boffa, M. B., Côté, G. P., & Koschinsky, M. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309705200 · Cited by 71 · see citing works

The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain.

Váli, Z., & Patthy, L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89800-3 · Cited by 69 · see citing works

Antifibrinolytic Effect of Recombinant Apolipoprotein(a) in Vitro Is Primarily Due to Attenuation of tPA-Mediated Glu-Plasminogen Activation

Sangrar, W., Bajzar, L., Nesheim, M. E., et al. (1995) · Biochemistry · doi:10.1021/bi00015a028 · Cited by 67 · see citing works

Visualization and identification of the structures formed during early stages of fibrin polymerization

Chernysh, I. N., Nagaswami, C., & Weisel, J. W. (2011) · Blood · doi:10.1182/blood-2010-07-297671 · Cited by 65 · see citing works

Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator

Urano, T., de Serrano, V. S., Gaffney, P. J., et al. (1988) · Biochemistry · doi:10.1021/bi00417a049 · Cited by 64 · see citing works

Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children

Goldenberg, N. A., Bernard, T. J., Hillhouse, J., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.073833 · Cited by 63 · see citing works

Apolipoprotein(a) inhibits the conversion of Glu‐plasminogen to Lys‐plasminogen: a novel mechanism for lipoprotein(a)‐mediated inhibition of plasminogen activation

Feric, N. T., Boffa, M. B., Johnston, S. M., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03183.x · Cited by 62 · see citing works

Lipids and carotid plaque in the Northern Manhattan Study (NOMAS)

Gardener, H. E., Della‐Morte, D., Elkind, M. S. V., Sacco, R. L., & Rundek, T. (2009) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-9-55 · Cited by 61 · see citing works

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins

Schneider, M., Witztum, J. L., Young, S. G., Ludwig, E. H., Miller, E. R., Tsimikas, S., Curtiss, L. K., Marcovina, S. M., Taylor, J. M., Lawn, R. M., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400467-jlr200 · Cited by 61 · see citing works

Binding of Recombinant Apolipoprotein(a) to Human Platelets and Effect on Platelet Aggregation

Martı́nez, C., Rivera, J., Loyau, S., et al. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615654 · Cited by 59 · see citing works

The Solution Phase Interaction between Apolipoprotein(a) and Plasminogen Inhibits the Binding of Plasminogen to a Plasmin-Modified Fibrinogen Surface

Sangrar, W., Gabel, B. R., Boffa, M. B., et al. (1997) · Biochemistry · doi:10.1021/bi962433d · Cited by 57 · see citing works

Apolipoprotein(a) Attenuates Endogenous Fibrinolysis in the Rabbit Jugular Vein Thrombosis Model In Vivo

Biemond, B. J., Friederich, P. W., Koschinsky, M. L., et al. (1997) · Circulation · doi:10.1161/01.cir.96.5.1612 · Cited by 56 · see citing works

Influence of plasma lipoprotein(a) levels on coronary vasomotor response to acetylcholine

Tsurumi, Y., Nagashima, H., Ichikawa, K., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00321-5 · Cited by 55 · see citing works

Toward an understanding of fibrin branching structure

Fogelson, A. L., & Keener, J. P. (2010) · Physical Review E · doi:10.1103/physreve.81.051922 · Cited by 55 · see citing works

Multiple Binding with Identical Linkage: A Mechanism That Explains the Effect of Lipoprotein(a) on Fibrinolysis

Hervio, L., Durlach, V., Girard-Globa, A., et al. (1995) · Biochemistry · doi:10.1021/bi00041a011 · Cited by 54 · see citing works

Ligand Preferences of Kringle 2 and Homologous Domains of Human Plasminogen: Canvassing Weak, Intermediate, and High-Affinity Binding Sites by1H-NMR

Marti, D. N., Hu, C.-K., An, S. S. A., et al. (1997) · Biochemistry · doi:10.1021/bi971316v · Cited by 54 · see citing works

Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with omega-amino acid ligands.

McCance, S. G., Menhart, N., & Castellino, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31649-1 · Cited by 53 · see citing works

Quantitative Evaluation of the Contribution of Weak Lysine-binding Sites Present within Apolipoprotein(a) Kringle IV Types 6–8 to Lipoprotein(a) Assembly

Becker, L., Cook, P. M., Wright, T. G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309414200 · Cited by 50 · see citing works

Comparison of ligand-binding sites of modeled apo[a] kringle-like sequences in human lipoprotein[a].

Guevara, J., Jan, A. Y., Knapp, R. D., et al. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.5.758 · Cited by 49 · see citing works

Lp(a) Particles Mold Fibrin-Binding Properties of Apo(a) in Size-Dependent Manner

Kang, C., Domínguez, M., Loyau, S., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000021144.87870.c8 · Cited by 49 · see citing works

Factor XI Regulates Pathological Thrombus Formation on Acutely Ruptured Atherosclerotic Plaques

van Montfoort, M. L., Kuijpers, M. J. E., Knaup, V. L., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303209 · Cited by 48 · see citing works

Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a).

Williams, J. K., Bellinger, D. A., Nichols, T. C., et al. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.548 · Cited by 48 · see citing works

The Structures of Domains of Blood Proteins

Tulinsky, A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646368 · Cited by 46 · see citing works

Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21 483 women

Danik, J. S., Buring, J. E., Chasman, D. I., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12056 · Cited by 45 · see citing works

Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase

Tsironis, L. D., Mitsios, J. V., Milionis, H. J., Elisaf, M., & Tselepis, A. D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.005 · Cited by 45 · see citing works

Lipoprotein[a] in the chimpanezee: relationship of apo[a] phenotype to elevated plasma Lp[a] levels.

Doucet, C., Huby, T., Chapman, J., & Thillet, J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41215-5 · Cited by 43 · see citing works

The course and prerequisites of Lys-plasminogen formation during fibrinolysis

Suenson, E., & Thorsen, S. (1988) · Biochemistry · doi:10.1021/bi00407a029 · Cited by 41 · see citing works

Lipid levels do not influence the risk of venous thromboembolism

Mahmoodi, B. K., Gansevoort, R. T., Muntinghe, F. L. H., Dullaart, R. P. F., Kluin‐Nelemans, H. C., Veeger, N. J. G. M., van Schouwenburg, I. M., & Meijer, K. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0426 · Cited by 40 · see citing works

The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin

Hervio, L., Girard-Globa, A., Durlach, V., et al. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.156288.x · Cited by 40 · see citing works

Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with .omega.-amino acids

Hoover, G. J., Menhart, N., Martin, A., et al. (1993) · Biochemistry · doi:10.1021/bi00092a002 · Cited by 40 · see citing works

Lipoprotein(a) in diet-induced atherosclerosis in nonhuman primates.

Nachman, R. L., Gavish, D., Azrolan, N., et al. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.32 · Cited by 40 · see citing works

Lipoprotein(a) concentration is not associated with venous thromboembolism in a case control study.

Lippi, G., Bassi, A., Brocco, G., et al. (1999) · PubMed · Cited by 39 · see citing works

Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction

von Hodenberg, E., Kreuzer, J., Hautmann, M. B., et al. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90464-v · Cited by 38 · see citing works

Elevated fibrinogen causes thrombosis

Ariëns, R. A. S. (2011) · Blood · doi:10.1182/blood-2011-03-340422 · Cited by 35 · see citing works

Lipoprotein(a) Isoforms Display Differences in Affinity for Plasminogen-Like Binding to Human Mononuclear Cells

Kang, C., Durlach, V., Soulat, T., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2036 · Cited by 35 · see citing works

Lipoprotein (a), LPA Ile4399Met, and Fibrin Clot Properties

Rowland, C. M., Pullinger, C. R., Luke, M. M., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.01.024 · Cited by 33 · see citing works

High‐resolution crystal structure of apolipoprotein(a) kringle IV type 7: Insights into ligand binding

Ye, Q., Rahman, M. N., Koschinsky, M. L., & Jia, Z. (2001) · Protein Science · doi:10.1110/ps.01701 · Cited by 31 · see citing works

Serum Lipoprotein(a) Level Is Related to Thrombin Generation and Spontaneous Intermittent Coronary Occlusion in Patients With Acute Myocardial Infarction

Haider, A. W., Andreotti, F., Thompson, G. R., Kluft, C., Maseri, A., & Davies, G. J. (1996) · Circulation · doi:10.1161/01.cir.94.9.2072 · Cited by 31 · see citing works

Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels

López, S., Buil, A., Ordóñez‐Llanos, J., Souto, J. C., Almasy, L. A., Lathrop, M. G., Blangero, J., Blanco‐Vaca, F., Fontcuberta, J., & Soria, J. M. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.114 · Cited by 31 · see citing works

Comparative Analyses of the Lysine Binding Site Properties of Apolipoprotein(a) Kringle IV Types 7 and 10

Rahman, M. N., Becker, L., Petrounevitch, V., et al. (2001) · Biochemistry · doi:10.1021/bi010964i · Cited by 31 · see citing works

Identification and Characterization of Novel Lysine-independent Apolipoprotein(a)-binding Sites in Fibrin(ogen) αC-domains

Tsurupa, G., Ho‐Tin‐Noé, B., Anglés‐Cano, E., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305154200 · Cited by 30 · see citing works

Influence of Lipoprotein (a) Levels and Isoforms on Fibrinolytic Activity – Study in Families with High Lipoprotein (a) Levels

Falcó, C., Dalmau, J., España, F., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615071 · Cited by 30 · see citing works

Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor

Barre, D. E. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.04.013 · Cited by 27 · see citing works

The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease

Bilgen, D., Sönmez, H. A., Ekmekçi, H., Ulutin, T., Öztürk, Z., Kökoǧlu, E., Gurel, C. B., Soner, A., & Domaniç, N. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.09.011 · Cited by 25 · see citing works

Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction

Junior, B. T., Chamone, D. F., Cobbaert, C. M., et al. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90737-6 · Cited by 24 · see citing works

Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.

Mbewu, A. D., Durrington, P. N., Mackness, M., et al. (1994) · Heart · doi:10.1136/hrt.71.4.316 · Cited by 23 · see citing works

Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts

Edelstein, C., Pfaffinger, D., Yang, M., Hill, J. S., & Scanu, A. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.009 · Cited by 22 · see citing works

Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction

Armstrong, V. W. (1990) · The Lancet · doi:10.1016/0140-6736(90)92557-x · Cited by 20 · see citing works

Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen

Sha, J., MCCULLOUGH, B., Hart, E., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01540.x · Cited by 19 · see citing works

The Thrombophilic Pattern of Different Clinical Manifestations of Venous Thromboembolism: A Survey of 443 Cases of Venous Thromboembolism

Grifoni, E., Marcucci, R., Ciuti, G., et al. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1301420 · Cited by 19 · see citing works

Lipoprotein(a) accelerates atherosclerosis in uremic mice

Pedersen, T. X., McCormick, S. P. A., Tsimikas, S., Bro, S., & Nielsen, L. B. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006742 · Cited by 19 · see citing works

Baboon Lipoprotein(a) Binds Very Weakly to Lysine−Agarose and Fibrin Despite the Presence of a Strong Lysine-Binding Site in Apolipoprotein(a) Kringle IV Type 10

Belczewski, A. R., Ho, J., Taylor, F. B., et al. (2004) · Biochemistry · doi:10.1021/bi048156p · Cited by 18 · see citing works

Lipoprotein (a) reduces platelet aggregation apo(a)-mediated decreases in production via thromboxane A 2

Barre, D. E. (1998) · Platelets · doi:10.1080/09537109876852 · Cited by 18 · see citing works

Apolipoprotein (a) mediates the lipoprotein (a)-induced biphasic shift in human platelet cyclic AMP

Barre, D. E. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2004.01.002 · Cited by 17 · see citing works

Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE

Rodger, M. A., Gal, G. L., Carrier, M., Betancourt, M. T., Kahn, S. R., Wells, P. S., Anderson, D. R., Lacut, K., Chagnon, I., Solymoss, S., et al. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.06.007 · Cited by 16 · see citing works

Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in non-patency

Brügemann, J., van der Meer, J., Hillege, H. L., et al. (1994) · International Journal of Cardiology · doi:10.1016/0167-5273(94)90265-8 · Cited by 15 · see citing works

Relationship Between Lipoprotein(a) and Spontaneous Recanalization of Infarct‐related Arteries in the Early Phase of Acute Myocardial Infarction

Kim, J. W., Seo, H. S., Suh, S. Y., et al. (2008) · Clinical Cardiology · doi:10.1002/clc.20143 · Cited by 14 · see citing works

Effects of high plasma lipoprotein (a) levels on tissue factor pathway inhibitor and the protein C pathway

Nisio, M. D., WOLDE, M. T., Meijers, J. C. M., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01517.x · Cited by 12 · see citing works

In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent

Knapp, J.-P., & Herrmann, W. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.205 · Cited by 9 · see citing works

Relation Between Serum Lipoprotein (a) and Residual Lesion Stenosis of Coronary Artery After Myocardial Infarction Without Reperfusion Therapy

Matsuda, S., Arima, M., Ohigawa, T., et al. (2004) · Japanese Heart Journal · doi:10.1536/jhj.45.397 · Cited by 9 · see citing works

Lipoprotein(a) and the risk of thromboembolism in Thai children

Sirachainan, N., Chaiyong, C., Visudtibhan, A., et al. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.11.002 · Cited by 4 · see citing works

Does Increased Lipoprotein (a) Impair the Effectiveness of Thrombolysis With Streptokinase?

Tokgozoglu, S. L., Özmen, F., Kabukçu, M., et al. (1995) · Angiology · doi:10.1177/000331979504600812 · Cited by 3 · see citing works

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601 · see citing works

A Test in Context: Lipoprotein(a)

Tsimikas, S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.042 · Cited by 1,137 · see citing works

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

Reyes-Soffer, G., Ginsberg, H. N., Berglund, L., Duell, P. B., Heffron, S. P., Kamstrup, P. R., Lloyd-Jones, D. M., Marcovina, S. M., Yeang, C., Koschinsky, M. L., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000147 · Cited by 836 · see citing works

Lipoprotein(a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

Nordestgaard, B. G., & Langsted, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r071233 · Cited by 575 · see citing works

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

Willeit, P., Ridker, P. M., Nestel, P. J., Simes, J., Tonkin, A. M., Pedersen, T. R., Schwartz, G. G., Olsson, A. G., Colhoun, H. M., Kronenberg, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31652-0 · Cited by 564 · see citing works

High lipoprotein(a) and high risk of mortality

Langsted, A., Kamstrup, P. R., & Nordestgaard, B. G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy902 · Cited by 288 · see citing works

Lipid-Lowering Agents: Targets Beyond PCSK9

Hegele, R. A., & Tsimikas, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313171 · Cited by 171 · see citing works

Update on the laboratory investigation of dyslipidemias

Ramasamy, I. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.01.015 · Cited by 50 · see citing works

The lipid paradox in neuroprogressive disorders: Causes and consequences

Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17 · see citing works

Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosis

Siudut, J., Natorska, J., Wypasek, E., Wiewiórka, Ł., Ostrowska-Kaim, E., Wiśniowska-Śmiałek, S., Plens, K., Musialek, P., Legutko, J., & Undas, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.01.011 · Cited by 16 · see citing works

Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease

Berg, K., Dahlén, G. H., & Frick, M. H. (1974) · Clinical Genetics · doi:10.1111/j.1399-0004.1974.tb00657.x · Cited by 319 · see citing works

Lipoprotein Lp(a) in lipoprotein spectrum indentified by Lipoprint LDL system.

Oravec, S., Dostal, E., & Gruber, K. (2013) · PubMed · Cited by 6 · see citing works

Lp(a) Lipoprotein/pre‐β1‐lipoprotein, serum lipids and atherosclerotic disease

Dahlén, G., Berg, K., & Frick, M. H. (1976) · Clinical Genetics · doi:10.1111/j.1399-0004.1976.tb01613.x · Cited by 54 · see citing works

식이성 단백질 함량에 따른 흰쥐에 사염화탄소 투여시 Lipoprotein 분획비의 변동

이혜자, 윤종국, & Lee, S. I. (1993)

Lp(a) LIPOPROTEIN AND PRE‐β1‐LIPOPROTEIN IN YOUNG ADULTS

Dahlén, G. H., Berg, K., Ramberg, U., et al. (1974) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1974.tb01018.x · Cited by 35 · see citing works